Detalhe da pesquisa
1.
Detecting deviations from the efficacy and safety results of single-arm trials using real-world data: The case of a CAR-T cell therapy in B-cell lymphoma.
Pharmacoepidemiol Drug Saf
; 30(4): 514-519, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33432654
2.
Potentials, challenges and future of chimeric antigen receptor T-cell therapy in non-Hodgkin lymphomas.
Acta Oncol
; 59(7): 766-774, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32189546
3.
Evaluating the effectiveness of risk minimisation measures: the application of a conceptual framework to Danish real-world dabigatran data.
Pharmacoepidemiol Drug Saf
; 26(6): 607-614, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28397317
4.
Balancing benefit and risk of medicines: a systematic review and classification of available methodologies.
Pharmacoepidemiol Drug Saf
; 23(7): 667-78, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24821575
5.
Use of angiotensin receptor blockers and the risk of cancer.
Circulation
; 123(16): 1729-36, 2011 Apr 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-21482967
6.
The Randomised Controlled Trial at the Intersection of Research Ethics and Innovation.
Pharmaceut Med
; 36(5): 287-293, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35877037
7.
Direct-acting oral anticoagulants (DOACs) in pregnancy: new insight from VigiBase®.
Sci Rep
; 9(1): 7236, 2019 05 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31076635
8.
Monitoring CAR-T-Cell Therapies Using the Nordic Healthcare Databases.
Pharmaceut Med
; 33(2): 83-88, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31933251
9.
The effectiveness of direct to healthcare professional communication - A systematic review of communication factor studies.
Res Social Adm Pharm
; 15(5): 475-482, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31130181
10.
On pharmaceutical risk minimization.
Drug Saf
; 31(9): 737-42, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-18707188
11.
Use of the dose, time, susceptibility (DoTS) classification scheme for adverse drug reactions in pharmacovigilance planning.
Drug Saf
; 29(7): 557-66, 2006.
Artigo
em Inglês
| MEDLINE | ID: mdl-16808549
12.
From protocol to published report: a study of consistency in the reporting of academic drug trials.
Trials
; 17: 100, 2016 Feb 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-26895826
13.
The precautionary principle and pharmaceutical risk management.
Drug Saf
; 28(6): 465-71, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-15924501
14.
The influence of lithium on the antidiuretic effect of desmopressin.
J Pharm Pharmacol
; 54(9): 1279-85, 2002 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-12356283
15.
A pharmacokinetic and pharmacodynamic study of desmopressin: evaluating sex differences and the effect of pre-treatment with piroxicam, and further validation of an indirect response model.
J Pharm Pharmacol
; 56(11): 1389-98, 2004 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-15525445
16.
Efficacy and safety of dabigatran etexilate and warfarin in "real-world" patients with atrial fibrillation: a prospective nationwide cohort study.
J Am Coll Cardiol
; 61(22): 2264-73, 2013 Jun 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-23562920
17.
Spontaneous reporting of adverse events following immunisation against pandemic influenza in Denmark November 2009-March 2010.
Vaccine
; 29(6): 1180-4, 2011 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21172382
18.
Temporal data mining for adverse events following immunization in nationwide Danish healthcare databases.
Drug Saf
; 33(11): 1015-25, 2010 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20925439
19.
Human papillomavirus immunisation of adolescent girls and anticipated reporting of immune-mediated adverse events.
Vaccine
; 27(22): 2954-8, 2009 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-19428906
20.
Reply: Dabigatran's 'real-world' data about risk of myocardial infarction and gastrointestinal bleeding contradicts with randomized trials.
J Am Coll Cardiol
; 62(10): 946-7, 2013 Sep 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-23810887